Another study showed that transgenic mice with cardiac myocyte-specific overexpression of Cav3 that were subjected to transverse aortic constriction had increased survival, reduced cardiac hypertrophy, and maintenance of cardiac function compared with control mice. This evidence concerns the gene CAV3 and cardiac hypertrophy.